Describing Patient With DME, Their Patient Journey and Disease Progression
NCT05966753 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 221004
Last updated 2024-12-19
Summary
This study aims to characterize patients with diabetic macular edema (DME), their progression, the treatment received and associate the functional and physiological outcomes related to the treatment.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-03
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
Imaging Parameters and DME Treatment Response
NCT02637245 ·Status: COMPLETED
-
Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.
NCT05959304 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)
NCT00457470 ·Status: WITHDRAWN ·Phase: PHASE2
-
Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)
NCT01947881 ·Status: COMPLETED
-
Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
NCT01934920 ·Status: UNKNOWN
-
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
NCT05978622 ·Status: ACTIVE_NOT_RECRUITING
-
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
NCT03590444 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema:
NCT05847088 ·Status: COMPLETED
-
Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.
NCT02581995 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema
NCT02732951 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study in Patients With Persistent Macular Edema
NCT00035906 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
NCT01168258 ·Status: TERMINATED
-
Diabetic Macular Edema Severity at Diagnosis
NCT00886392 ·Status: COMPLETED
-
4D-150 in Patients With Diabetic Macular Edema
NCT05930561 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dextromethorphan for Diabetic Macular Edema
NCT01441102 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Combination Steroid and Anti-VEGF for Persistent DME
NCT01945866 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
NCT00308477 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）
NCT06908876 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
NCT05224102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema
NCT06422507 ·Status: COMPLETED ·Phase: PHASE3
-
Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.
NCT04601675 ·Status: UNKNOWN ·Phase: NA
-
OCT-angiography in Diabetic Patients
NCT02870803 ·Status: UNKNOWN
-
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
NCT02503540 ·Status: COMPLETED ·Phase: PHASE4
-
Brolucizumab Versus Aflibercept on Visual and Anatomical Outcomes in Diabetic Macular Edema
NCT07096713 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
NCT02121262 ·Status: COMPLETED ·Phase: PHASE3